tiprankstipranks
Trending News
More News >
Marchex (MCHX)
NASDAQ:MCHX

Marchex (MCHX) AI Stock Analysis

Compare
191 Followers

Top Page

MCHX

Marchex

(NASDAQ:MCHX)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 4o)
Rating:55Neutral
Price Target:
$1.50
▼(-10.71% Downside)
Marchex's overall stock score reflects significant financial challenges, particularly in profitability and cash flow. Despite these issues, the company's strategic initiatives, including acquisitions and product launches, provide a basis for potential future growth. Technical indicators and valuation metrics present a mixed picture, with some positive momentum but also significant valuation concerns.
Positive Factors
Strategic Acquisitions
The acquisition of Archenia is expected to enhance Marchex's AI-driven platform, potentially increasing market reach and revenue scale, supporting long-term growth.
Product Launches
New product launches and increased sales bookings indicate strong market demand and operational capability, supporting future revenue growth and competitive positioning.
Low Leverage
A low debt-to-equity ratio suggests financial stability and flexibility, allowing Marchex to invest in growth opportunities without significant financial strain.
Negative Factors
Negative Profit Margins
Persistent negative profit margins highlight operational inefficiencies and profitability challenges, potentially limiting reinvestment in growth initiatives.
Declining Revenue
A decline in revenue suggests challenges in maintaining market share and customer retention, which could impact long-term growth prospects.
Weak Cash Flow
Weak cash flow generation undermines the company's ability to fund operations and strategic initiatives, posing risks to financial sustainability.

Marchex (MCHX) vs. SPDR S&P 500 ETF (SPY)

Marchex Business Overview & Revenue Model

Company DescriptionMarchex, Inc. is a leading provider of call analytics and conversation intelligence solutions, primarily serving businesses in the advertising and marketing sectors. The company specializes in helping clients optimize their customer interactions and improve marketing ROI through data-driven insights derived from phone calls and other voice interactions. Marchex offers a suite of products that includes call tracking, call management, and analytics services, which enable businesses to understand customer behavior and make informed decisions based on real-time data.
How the Company Makes MoneyMarchex generates revenue through a combination of subscription fees and performance-based pricing models. Its primary revenue streams include the sale of call tracking services, which allow businesses to track and analyze incoming calls from various advertising channels. Additionally, the company earns money from its conversation analytics platform, which provides actionable insights based on customer phone interactions. Key partnerships with major advertising platforms and agencies enhance Marchex's market reach and effectiveness, while its focus on delivering high-quality analytics helps attract and retain a diverse client base across multiple industries.

Marchex Earnings Call Summary

Earnings Call Date:Nov 13, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 03, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mix of positive and negative aspects. While there were notable achievements in strategic positioning, product launches, and the potential acquisition of Archenia, there were also challenges such as a slight revenue decline and expected lower performance in Q4 2025. Overall, the company appears optimistic about future growth and profitability.
Q3-2025 Updates
Positive Updates
Strategic Inflection Point
The company is at a positive inflection point, strategically and operationally, with an expansion of customer footprint, product capabilities, and sales momentum.
New Product Launches and Increased Sales Bookings
In Q3 2025, there was progress with launching new products and accelerating sales bookings to the highest levels of the year.
Improved Sequential Adjusted EBITDA
Despite revenue migration dilution, there was a significant improvement in sequential adjusted EBITDA, demonstrating operating leverage.
Agreement to Acquire Archenia
Marchex announced an agreement in principle to acquire Archenia, potentially enhancing its AI-driven customer acquisition and outcome optimization platform.
Potential Revenue Growth and EBITDA Margins
Projected revenue growth on a run rate basis in the 10% range for 2026, with adjusted EBITDA margins of 10% or more.
Negative Updates
Revenue Decline
Revenue for Q3 2025 was $11.5 million, down from $11.7 million in Q2 2025, due to migration activities from legacy platforms.
Cash Decrease
Cash decreased to $10.3 million from $10.5 million at the end of Q2 2025, primarily due to the timing of customer payments.
Expected Sequential Decline in Q4 2025
Revenue and adjusted EBITDA are anticipated to be sequentially lower in Q4 2025 due to seasonality and revenue migration dilution.
Company Guidance
In the Q3 2025 earnings call, Marchex provided several key metrics and forward-looking guidance. Revenue for the third quarter was reported at $11.5 million, slightly down from $11.7 million in the previous quarter. Despite this, the company experienced significant increases in sales bookings and sequential adjusted EBITDA improvements, indicating strong operating leverage. Looking ahead to 2026, Marchex anticipates revenue growth of around 10% on a run-rate basis by year-end, driven by new product launches and sales expansion. The company also expects adjusted EBITDA margins to reach 10% or higher as operating expenses decrease. Additionally, Marchex announced an agreement to acquire Archenia, projecting the combined entity could achieve a revenue run-rate of approximately $60 million annually with growth rates of 15% to 20%, while also targeting Rule of 30 to Rule of 40 metrics, combining revenue growth and EBITDA margins.

Marchex Financial Statement Overview

Summary
Marchex faces significant financial challenges, particularly in profitability and cash flow generation. Despite a strong equity position with low leverage, the company struggles with negative profit margins and declining revenue, indicating a need for strategic interventions.
Income Statement
45
Neutral
Marchex's income statement reveals challenges in profitability and revenue growth. The TTM data shows a negative net profit margin of -9.76% and a declining revenue growth rate of -2.18%. Despite a relatively stable gross profit margin of 64.54%, the company struggles with negative EBIT and EBITDA margins, indicating operational inefficiencies. The consistent decline in revenue over the years highlights a need for strategic adjustments to reverse this trend.
Balance Sheet
55
Neutral
The balance sheet shows a strong equity position with a low debt-to-equity ratio of 0.027, indicating low leverage and financial stability. However, the return on equity is negative at -15.09%, reflecting the company's inability to generate profits from its equity base. The equity ratio stands at a healthy level, suggesting a solid capital structure, but the negative ROE points to inefficiencies in utilizing shareholder funds.
Cash Flow
40
Negative
Cash flow analysis indicates significant challenges, with negative operating and free cash flows. The free cash flow growth rate is -45.09%, highlighting a deterioration in cash generation capabilities. The operating cash flow to net income ratio is negative, suggesting that the company is not converting its accounting profits into cash effectively. Despite a high free cash flow to net income ratio, the overall cash flow position remains weak.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue46.49M48.12M49.91M52.17M53.48M51.22M
Gross Profit29.62M30.95M29.33M31.71M31.78M30.33M
EBITDA-2.34M-1.80M-5.76M-4.03M1.85M-36.66M
Net Income-4.83M-4.95M-9.91M-8.24M-4.39M-38.45M
Balance Sheet
Total Assets41.15M43.20M47.48M56.79M65.83M76.93M
Cash, Cash Equivalents and Short-Term Investments10.32M12.77M14.61M20.47M27.09M33.85M
Total Debt802.00K1.22M2.10M1.64M3.26M10.09M
Total Liabilities9.20M10.57M11.61M12.68M14.32M24.24M
Stockholders Equity31.94M32.63M35.87M44.11M51.50M52.69M
Cash Flow
Free Cash Flow-850.00K-1.53M-5.77M-5.16M-7.69M-4.73M
Operating Cash Flow-654.00K-1.10M-4.39M-2.29M-6.34M-3.37M
Investing Cash Flow-1.06M-429.00K-1.31M-2.87M-951.00K981.00K
Financing Cash Flow-46.00K-307.00K-160.00K-1.46M528.00K-5.49M

Marchex Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1.68
Price Trends
50DMA
1.69
Negative
100DMA
1.81
Negative
200DMA
1.79
Negative
Market Momentum
MACD
<0.01
Negative
RSI
55.37
Neutral
STOCH
50.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MCHX, the sentiment is Neutral. The current price of 1.68 is above the 20-day moving average (MA) of 1.62, below the 50-day MA of 1.69, and below the 200-day MA of 1.79, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 55.37 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for MCHX.

Marchex Risk Analysis

Marchex disclosed 32 risk factors in its most recent earnings report. Marchex reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Marchex Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
60
Neutral
$48.67B4.58-11.27%4.14%2.83%-41.78%
55
Neutral
$72.88M-15.14-14.61%-4.32%-13.99%
48
Neutral
$40.46M-8.75-38.21%25.10%50.62%
47
Neutral
$23.80M-4.46-26.62%-11.07%82.06%
41
Neutral
$3.01M-0.05-62.46%-12.90%
38
Underperform
$60.58M-1.82-127.41%-18.94%37.05%
* Communication Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MCHX
Marchex
1.68
-0.31
-15.58%
HHS
Harte-Hanks
3.29
-2.12
-39.19%
INUV
Inuvo
2.64
-1.59
-37.59%
FLNT
Fluent
2.09
-0.63
-23.16%
DRCT
Direct Digital Holdings
0.06
-0.49
-89.09%
TZUP
Thumzup Media Corporation
3.40
0.24
7.59%

Marchex Corporate Events

Executive/Board ChangesShareholder MeetingsBusiness Operations and Strategy
Marchex Completes Annual Stockholder Meeting and Approvals
Positive
Dec 17, 2025

On December 16, 2025, Marchex held its annual meeting of stockholders, during which all directors were re-elected and an independent registered public accounting firm was ratified. Following the meeting, Marchex’s Compensation Committee approved stock option grants for its directors as part of their annual board service, with a total of 50,000 options issued to each director under the 2021 Stock Incentive Plan. Directors will also receive quarterly cash compensation, aiming to strengthen corporate governance and align leadership incentives. These strategic decisions reflect the company’s efforts to foster stability in its board of directors while maintaining transparency for stakeholders.

M&A TransactionsBusiness Operations and StrategyFinancial Disclosures
Marchex Announces Acquisition of Archenia, Inc.
Positive
Nov 13, 2025

On November 13, 2025, Marchex announced an agreement in principle to acquire Archenia, Inc., a performance-based customer qualification company, for $10 million in convertible promissory notes. This acquisition aims to create a vertically focused, AI-driven customer acquisition platform, potentially enhancing Marchex’s revenue scale, market reach, and strategic flexibility. Additionally, Marchex reported its third-quarter 2025 financial results, highlighting a decrease in GAAP revenue to $11.5 million compared to the previous year, but an improvement in adjusted EBITDA to $1.1 million. The company is optimistic about its future growth prospects, anticipating a 10% revenue growth in 2026 due to its ongoing product launches and technology platform migration.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 19, 2025